Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CEBPG antibody (AA 1-150)

CEBPG Reactivity: Human WB, IHC, IP, ICC Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN1858360
  • Target See all CEBPG Antibodies
    CEBPG (CCAAT/enhancer Binding Protein (C/EBP), gamma (CEBPG))
    Binding Specificity
    • 15
    • 14
    • 9
    • 8
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-150
    Reactivity
    • 57
    • 25
    • 16
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Host
    • 52
    • 5
    • 1
    Rabbit
    Clonality
    • 54
    • 4
    Polyclonal
    Conjugate
    • 27
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    This CEBPG antibody is un-conjugated
    Application
    • 49
    • 25
    • 13
    • 13
    • 11
    • 7
    • 5
    • 5
    • 3
    • 3
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Purpose
    Polyclonal Antibody to CCAAT/Enhancer Binding Protein Gamma (CEBPg)
    Specificity
    The antibody is a rabbit polyclonal antibody raised against CEBPg. It has been selected for its ability to recognize CEBPg in immunohistochemical staining and western blotting.
    Cross-Reactivity
    Mouse, Rat
    Purification
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogen
    Recombinant CCAAT/Enhancer Binding Protein Gamma (CEBPg) corresdonding to Met1~Gln150 (Accession # P53567)
    Isotype
    IgG
    Top Product
    Discover our top product CEBPG Primary Antibody
  • Application Notes

    Western blotting: 0.5-2 μg/mL

    Immunohistochemistry: 5-20 μg/mL

    Immunocytochemistry: 5-20 μg/mL

    Optimal working dilutions must be determined by end user.

    Comment

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
    Preservative
    ProClin
    Precaution of Use
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Handling Advice
    Avoid repeated freeze-thaw cycles.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Expiry Date
    24 months
  • Target
    CEBPG (CCAAT/enhancer Binding Protein (C/EBP), gamma (CEBPG))
    Alternative Name
    CCAAT/Enhancer Binding Protein Gamma (CEBPG Products)
    Synonyms
    c/ebpg antibody, fc79a10 antibody, fi57b02 antibody, wu:fc79a10 antibody, wu:fi57b02 antibody, gpe1bp antibody, ig/ebp-1 antibody, MGC114733 antibody, GPE1BP antibody, IG/EBP-1 antibody, C/EBP[g] antibody, C/EBPgamma antibody, GPE1-BP antibody, Gpe1bp antibody, Ig/EBP antibody, C/EBP antibody, CEBPRNA antibody, CCAAT/enhancer binding protein (C/EBP), gamma antibody, CCAAT/enhancer binding protein gamma antibody, CCAAT/enhancer binding protein gamma L homeolog antibody, cebpg antibody, CEBPG antibody, cebpg.L antibody, Cebpg antibody
    Background
    CEBP-G, GPE1BP, IG/EBP-1
    Pathways
    Positive Regulation of Response to DNA Damage Stimulus
You are here:
Support